Colchicine in Patients at Cardiac Risk Undergoing Major Non-Cardiac Surgery
Conditions: Cardiovascular Diseases; Cardiovascular Complication; Perioperative Complication; Myocardial Infarction Interventions: Drug: Colchicine; Drug: Placebo Sponsors: Cantonal Hospital of St. Gallen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2024 Category: Research Source Type: clinical trials

Genomic Medicine Risk Assessment Care for Everyone - Implementation Phase
Conditions: Cardiovascular Diseases; Cancer; Liver Diseases; Hyperthermia Interventions: Behavioral: Disease Risk Assessment Sponsors: Duke University; National Human Genome Research Institute (NHGRI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2024 Category: Research Source Type: clinical trials

Cardiac Denervation Ablation Strategy for Severe Sinus Bradycardia
Conditions: Sinus Bradycardia Sponsors: China National Center for Cardiovascular Diseases Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2024 Category: Research Source Type: clinical trials

Polymorphism of ApoE in Alzheimer's Disease: Genetic Study in Castile and Leon (Spain)
Conditions: Alzheimer Disease Interventions: Diagnostic Test: Kit Buccal swab collection& stabilization de Canvax ®; Other: Cholesterol levels according to ApoE Genotype; Other: Assessing cardiovascular risk factors in all participants Sponsors: Universidad de Le ón; Consejo General de Colegios Oficiales de Enfermería España Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2024 Category: Research Source Type: clinical trials

Chinese Occupational Population Cohort of Lifestyle and Physical Fitness (LiFitChina)
Conditions: Lifestyle; Physical Fitness; Cardiovascular Diseases Sponsors: China National Center for Cardiovascular Diseases Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2024 Category: Research Source Type: clinical trials

Integrated Assessment of Cervicocerebral Vessels to Improve the Brain Injury for CAGB Patients (IACV Study)
Conditions: Coronary Disease; Coronary Artery Bypass; Strokes Thrombotic Interventions: Other: Integrated Assessment of Cervicocerebral Vessels Sponsors: China National Center for Cardiovascular Diseases Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2024 Category: Research Source Type: clinical trials

Early Intervention to Promote Cardiovascular Health of Mothers and Children
Conditions: Cardiovascular Health Interventions: Behavioral: Enriched home visiting; Behavioral: Routine home visiting Sponsors: JHSPH Center for Clinical Trials; National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2024 Category: Research Source Type: clinical trials

Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3)
Conditions: High Cardiovascular Risk; Hypertension Interventions: Drug: Zilebesiran; Drug: Placebo Sponsors: Alnylam Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2024 Category: Research Source Type: clinical trials

MagicTouch ™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels
Conditions: Coronary Artery Disease; Native Coronary Artery Stenosis; Cardiovascular Diseases Interventions: Device: Sirolimus Drug Coated Balloon; Device: Drug eluting stents (DES) Sponsors: Concept Medical Inc.; Cardiovascular Research Foundation, New York Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2024 Category: Research Source Type: clinical trials

Vital Signs Blood Pressure Trial
Conditions: Cardiovascular Diseases; Hypertension; Blood Pressure Interventions: Other: Blood Pressure Cuff, EKG, PPG Sponsors: Stanford University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2024 Category: Research Source Type: clinical trials

Reprieve System Pilot Study
Conditions: Acute Decompensated Heart Failure Interventions: Device: Reprieve System Sponsors: Reprieve Cardiovascular, Inc Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2024 Category: Research Source Type: clinical trials

Effects of Exercise Training in Survivors of Lymphoma
Conditions: Lymphoma; Physical Exercise; Cardiotoxicity; Cardiovascular Diseases; Chemotherapeutic Toxicity Interventions: Behavioral: Aerobic Exercise; Behavioral: Combined Aerobic and Resistance Exercise Sponsors: Norwegian School of Sport Sciences; Uppsala University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2024 Category: Research Source Type: clinical trials

Acute Effects of Legume-enriched Meals Compared to Western Diet Meals on Postprandial Metabolism in Participants With Increased Cardiometabolic Risk
Conditions: Cardiovascular Diseases; Metabolic Syndrome Interventions: Other: High Protein Planetary Health Diet; Other: Low Protein Planetary Health Diet; Other: High Protein Western Diet; Other: Low Protein Western Diet Sponsors: University of Bonn; Federal Ministry of Food and Agriculture (BMEL); Federal Office for Agriculture and Food (BLE) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2024 Category: Research Source Type: clinical trials

A Study to Understand How Continuous Glucose Monitors Impact Eating Behavior
Conditions: Weight Loss Interventions: Other: CGM Sponsors: Midwest Center for Metabolic and Cardiovascular Research Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2024 Category: Research Source Type: clinical trials

A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM
Conditions: Neoplasms, Plasma Cell; Neoplasms by Histologic Type; Neoplasms; Hemostatic Disorders; Vascular Diseases; Cardiovascular Diseases; Paraproteinemias; Blood Protein Disorders; Hematologic Diseases; Hemorrhagic Disorders; Lymphoproliferative Disorders; Immunoproliferative Disorders; Immune System Diseases; Multiple Myeloma Interventions: Drug: OriCAR-017 Sponsors: OriCell Therapeutics Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2024 Category: Research Source Type: clinical trials